vs
Side-by-side financial comparison of APA Corporation (APA) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
APA Corporation is the larger business by last-quarter revenue ($2.2B vs $1.1B, roughly 2.0× PERRIGO Co plc). APA Corporation runs the higher net margin — 15.0% vs -127.8%, a 142.8% gap on every dollar of revenue. On growth, PERRIGO Co plc posted the faster year-over-year revenue change (-2.5% vs -24.3%). Over the past eight quarters, APA Corporation's revenue compounded faster (1.4% CAGR vs 1.3%).
APA Corporation, a holding company for Apache Corporation, an American company engaged in hydrocarbon exploration. It is organized in Delaware and headquartered in Houston.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
APA vs PRGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.2B | $1.1B |
| Net Profit | $331.0M | $-1.4B |
| Gross Margin | — | 32.6% |
| Operating Margin | 32.5% | -116.0% |
| Net Margin | 15.0% | -127.8% |
| Revenue YoY | -24.3% | -2.5% |
| Net Profit YoY | -22.1% | -3093.9% |
| EPS (diluted) | $0.79 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.2B | $1.1B | ||
| Q3 25 | $2.3B | $1.0B | ||
| Q2 25 | $2.3B | $1.1B | ||
| Q1 25 | $2.7B | $1.0B | ||
| Q4 24 | $2.9B | $1.1B | ||
| Q3 24 | $2.7B | $1.1B | ||
| Q2 24 | $2.8B | $1.1B | ||
| Q1 24 | $2.1B | $1.1B |
| Q4 25 | $331.0M | $-1.4B | ||
| Q3 25 | $205.0M | $7.5M | ||
| Q2 25 | $603.0M | $-8.4M | ||
| Q1 25 | $418.0M | $-6.4M | ||
| Q4 24 | $425.0M | $-44.4M | ||
| Q3 24 | $-223.0M | $-21.0M | ||
| Q2 24 | $541.0M | $-108.4M | ||
| Q1 24 | $212.0M | $2.0M |
| Q4 25 | — | 32.6% | ||
| Q3 25 | — | 36.1% | ||
| Q2 25 | — | 34.4% | ||
| Q1 25 | — | 37.6% | ||
| Q4 24 | — | 33.9% | ||
| Q3 24 | — | 37.2% | ||
| Q2 24 | — | 37.0% | ||
| Q1 24 | — | 33.1% |
| Q4 25 | 32.5% | -116.0% | ||
| Q3 25 | 33.7% | 7.0% | ||
| Q2 25 | 31.8% | 4.3% | ||
| Q1 25 | 31.9% | 4.5% | ||
| Q4 24 | 31.4% | 10.0% | ||
| Q3 24 | -5.2% | 7.4% | ||
| Q2 24 | 34.4% | -2.5% | ||
| Q1 24 | 32.2% | -5.1% |
| Q4 25 | 15.0% | -127.8% | ||
| Q3 25 | 9.0% | 0.7% | ||
| Q2 25 | 26.0% | -0.8% | ||
| Q1 25 | 15.4% | -0.6% | ||
| Q4 24 | 14.6% | -3.9% | ||
| Q3 24 | -8.1% | -1.9% | ||
| Q2 24 | 19.0% | -10.2% | ||
| Q1 24 | 9.9% | 0.2% |
| Q4 25 | $0.79 | $-10.23 | ||
| Q3 25 | $0.57 | $0.05 | ||
| Q2 25 | $1.67 | $-0.06 | ||
| Q1 25 | $0.96 | $-0.05 | ||
| Q4 24 | $0.97 | $-0.32 | ||
| Q3 24 | $-0.60 | $-0.15 | ||
| Q2 24 | $1.46 | $-0.79 | ||
| Q1 24 | $0.44 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $516.0M | — |
| Total DebtLower is stronger | $4.3B | — |
| Stockholders' EquityBook value | $6.1B | $2.9B |
| Total Assets | $17.8B | $8.5B |
| Debt / EquityLower = less leverage | 0.70× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $516.0M | — | ||
| Q3 25 | $475.0M | $432.1M | ||
| Q2 25 | $107.0M | $454.2M | ||
| Q1 25 | $67.0M | $409.9M | ||
| Q4 24 | $625.0M | $558.8M | ||
| Q3 24 | $64.0M | $1.5B | ||
| Q2 24 | $160.0M | $542.8M | ||
| Q1 24 | $102.0M | $658.5M |
| Q4 25 | $4.3B | — | ||
| Q3 25 | $4.3B | — | ||
| Q2 25 | $4.3B | — | ||
| Q1 25 | $5.2B | — | ||
| Q4 24 | $6.0B | — | ||
| Q3 24 | $6.4B | — | ||
| Q2 24 | $6.7B | — | ||
| Q1 24 | $5.2B | — |
| Q4 25 | $6.1B | $2.9B | ||
| Q3 25 | $6.0B | $4.4B | ||
| Q2 25 | $5.9B | $4.5B | ||
| Q1 25 | $5.4B | $4.4B | ||
| Q4 24 | $5.3B | $4.3B | ||
| Q3 24 | $5.1B | $4.6B | ||
| Q2 24 | $5.4B | $4.5B | ||
| Q1 24 | $2.6B | $4.7B |
| Q4 25 | $17.8B | $8.5B | ||
| Q3 25 | $17.7B | $10.1B | ||
| Q2 25 | $18.1B | $10.1B | ||
| Q1 25 | $18.5B | $9.8B | ||
| Q4 24 | $19.4B | $9.6B | ||
| Q3 24 | $19.4B | $11.2B | ||
| Q2 24 | $20.2B | $10.4B | ||
| Q1 24 | $15.0B | $10.6B |
| Q4 25 | 0.70× | — | ||
| Q3 25 | 0.72× | — | ||
| Q2 25 | 0.73× | — | ||
| Q1 25 | 0.96× | — | ||
| Q4 24 | 1.13× | — | ||
| Q3 24 | 1.25× | — | ||
| Q2 24 | 1.24× | — | ||
| Q1 24 | 1.99× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $808.0M | $175.4M |
| Free Cash FlowOCF − Capex | — | $148.6M |
| FCF MarginFCF / Revenue | — | 13.4% |
| Capex IntensityCapex / Revenue | — | 2.4% |
| Cash ConversionOCF / Net Profit | 2.44× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $808.0M | $175.4M | ||
| Q3 25 | $1.5B | $51.7M | ||
| Q2 25 | $1.2B | $75.9M | ||
| Q1 25 | $1.1B | $-64.5M | ||
| Q4 24 | $1.0B | $312.6M | ||
| Q3 24 | $1.3B | $42.2M | ||
| Q2 24 | $877.0M | $9.5M | ||
| Q1 24 | $368.0M | $-1.4M |
| Q4 25 | — | $148.6M | ||
| Q3 25 | — | $29.8M | ||
| Q2 25 | — | $56.7M | ||
| Q1 25 | — | $-90.0M | ||
| Q4 24 | — | $274.9M | ||
| Q3 24 | — | $15.1M | ||
| Q2 24 | — | $-18.9M | ||
| Q1 24 | — | $-26.5M |
| Q4 25 | — | 13.4% | ||
| Q3 25 | — | 2.9% | ||
| Q2 25 | — | 5.4% | ||
| Q1 25 | — | -8.6% | ||
| Q4 24 | — | 24.2% | ||
| Q3 24 | — | 1.4% | ||
| Q2 24 | — | -1.8% | ||
| Q1 24 | — | -2.4% |
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 2.1% | ||
| Q2 25 | — | 1.8% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | 3.3% | ||
| Q3 24 | — | 2.5% | ||
| Q2 24 | — | 2.7% | ||
| Q1 24 | — | 2.3% |
| Q4 25 | 2.44× | — | ||
| Q3 25 | 7.12× | 6.89× | ||
| Q2 25 | 1.96× | — | ||
| Q1 25 | 2.62× | — | ||
| Q4 24 | 2.44× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.62× | — | ||
| Q1 24 | 1.74× | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
APA
| Oil And Gas Excluding Purchased | $1.7B | 76% |
| Oil And Gas Purchased | $323.0M | 15% |
| Oil Reserves | $114.0M | 5% |
| Other | $72.0M | 3% |
| Natural Gas Reserves | $30.0M | 1% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
